FOSTER CITY, Calif. & BANGALORE, India--(BUSINESS WIRE)--Entelos, Inc. (LSE:ENTL), a U.S.-based life sciences company building predictive computer models of human physiology and “virtual patients” for drug discovery and development, and Jubilant BioSys Ltd., a premier drug discovery and development services company based in India, announced today a broad strategic alliance to: i) help discover, in-license, and further develop a portfolio of compounds; and ii) jointly develop and offer an integrated spectrum of services to expand their respective businesses with existing and future pharmaceutical and biotechnology partners.
